Evidence map›Paper›PMID 9784538›Full record

ArticleInfection and immunity1998

1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line.

K A Rockett, R Brookes, I Udalova, V Vidal, A V Hill, D Kwiatkowski

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03984890 (Effect of Vitamin D3 Supplementation on Chronic Granulomatous Disease Patients With BCGosis/Itis), which is not on this map. Cited by 103 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 4 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03984890 phase2 / phase3completednot on this mapstarted 2019, after this paper: background citation

Effect of Vitamin D3 Supplementation on Chronic Granulomatous Disease Patients With BCGosis/Itis

TypeinterventionalSponsorChildren's Hospital of Fudan UniversityRan2019 to 2023Enrolled50ConditionsVitamin D3, Chronic-granulomatous Disease, BCGArmsVitamin D3, Traditional treatment of CGD and TB
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 4 syntheses or guidelines pooled it, 304 citations in OpenAlex.

  1. Pooled it
  2. Vitamin DBMC infectious diseases · 2023
    Pooled it
  3. Pooled it
  4. Bioscience reports · 2017
    Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Research progress on genetic control of host susceptibility to tuberculosis.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2022
    Review
  15. Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Molecular mechanism of interaction ofBiochemistry and biophysics reports · 2021
    Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K A RockettMolecular Infectious Disease Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom. krockett@hammer.imm.ox.ac.uk
R Brookes
I Udalova
V Vidal
A V Hill
D Kwiatkowski
John Radcliffe Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inducible synthesis of nitric oxide (NO) by macrophages is an important mechanism of the host defense against intracellular infection in mice, but the evidence for significant levels of inducible NO production by human macrophages is controversial. Here we report that the human promyelocytic cell line HL-60, when differentiated to a macrophage-like phenotype, acquires the ability to produce substantial amounts of NO on stimulation with LPS or 1, 25-dihydroxyvitamin D3 (1,25-D3) in the absence of activating factors such as gamma interferon. Expression of the inducible nitric oxide synthase (NOS2) was confirmed by sequencing of the reverse transcription-PCR product from stimulated HL-60 cells. Kinetic studies after lipopolysaccharide stimulation show that NOS2 mRNA levels rise within 3 to 6 h, that conversion of [14C]arginine to [14C]citrulline is maximal at 5 to 6 days, and that levels of reactive nitrogen intermediates stabilize at around 20 microM at 7 to 8 days. We find that 1,25-D3 acts to suppress the growth of Mycobacterium tuberculosis in these cells and that this effect is inhibited by NG-monomethyl-L-arginine, suggesting that vitamin D-induced NO production may play a role in the host defense against human tuberculosis.

Indexed as

CalcitriolCarbon DioxideEnzyme InductionGene Expression Regulation, EnzymologicHL-60 CellsHumansKineticsMacrophagesMycobacterium tuberculosisNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IIVitamin DCalcitriolCarbon DioxideNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINOS2 protein, humanVitamin D

Identifiers

PMID9784538
PMCPMC108664
OpenAlexW2146349024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.